327 related articles for article (PubMed ID: 25686679)
1. HAART slows progression to anal cancer in HIV-infected MSM.
Duncan KC; Chan KJ; Chiu CG; Montaner JS; Coldman AJ; Cescon A; Au-Yeung CG; Wiseman SM; Hogg RS; Press NM
AIDS; 2015 Jan; 29(3):305-11. PubMed ID: 25686679
[TBL] [Abstract][Full Text] [Related]
2. Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men.
Palefsky JM; Holly EA; Efirdc JT; Da Costa M; Jay N; Berry JM; Darragh TM
AIDS; 2005 Sep; 19(13):1407-14. PubMed ID: 16103772
[TBL] [Abstract][Full Text] [Related]
3. High rates of anal dysplasia in HIV-infected men who have sex with men, women, and heterosexual men.
Gaisa M; Sigel K; Hand J; Goldstone S
AIDS; 2014 Jan; 28(2):215-22. PubMed ID: 24072194
[TBL] [Abstract][Full Text] [Related]
4. Anal cancers among HIV-infected persons: HAART is not slowing rising incidence.
Crum-Cianflone NF; Hullsiek KH; Marconi VC; Ganesan A; Weintrob A; Barthel RV; Agan BK;
AIDS; 2010 Feb; 24(4):535-43. PubMed ID: 19926961
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy.
Piketty C; Darragh TM; Heard I; Da Costa M; Bruneval P; Kazatchkine MD; Palefsky JM
Sex Transm Dis; 2004 Feb; 31(2):96-9. PubMed ID: 14743072
[TBL] [Abstract][Full Text] [Related]
6. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
Wong KH; Chan KC; Lee SS
Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
[TBL] [Abstract][Full Text] [Related]
7. Impact of screening and antiretroviral therapy on anal cancer incidence in HIV-positive MSM.
Blaser N; Bertisch B; Kouyos RD; Calmy A; Bucher HC; Cavassini M; Estill J; Keiser O; Egger M;
AIDS; 2017 Aug; 31(13):1859-1866. PubMed ID: 28746085
[TBL] [Abstract][Full Text] [Related]
8. Progression to and spontaneous regression of high-grade anal squamous intraepithelial lesions in HIV-infected and uninfected men.
Tong WW; Jin F; McHugh LC; Maher T; Sinclair B; Grulich AE; Hillman RJ; Carr A
AIDS; 2013 Sep; 27(14):2233-43. PubMed ID: 24157904
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV Cohort Study.
Bertisch B; Franceschi S; Lise M; Vernazza P; Keiser O; Schöni-Affolter F; Bouchardy C; Dehler S; Levi F; Jundt G; Ess S; Pawlita M; Kovari H; Wandeler G; Calmy A; Cavassini M; Stöckle M; Clifford G;
Am J Epidemiol; 2013 Sep; 178(6):877-84. PubMed ID: 23900553
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus antibody response following HAART initiation among MSM.
Combes JD; Clifford GM; Egger M; Cavassini M; Hirsch HH; Hauser C; Calmy A; Schmid P; Bernasconi E; Günthard HF; Franceschi S; Waterboer T; Scherrer AU;
AIDS; 2017 Feb; 31(4):561-569. PubMed ID: 28121669
[TBL] [Abstract][Full Text] [Related]
11. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
[TBL] [Abstract][Full Text] [Related]
12. Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for invasive anal carcinoma in human immunodeficiency virus-positive patients receiving highly active antiretroviral therapy.
Fraunholz I; Weiss C; Eberlein K; Haberl A; Rödel C
Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1425-32. PubMed ID: 19744801
[TBL] [Abstract][Full Text] [Related]
13. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
[TBL] [Abstract][Full Text] [Related]
14. Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment: results from the french hospital database on HIV.
Piketty C; Selinger-Leneman H; Bouvier AM; Belot A; Mary-Krause M; Duvivier C; Bonmarchand M; Abramowitz L; Costagliola D; Grabar S
J Clin Oncol; 2012 Dec; 30(35):4360-6. PubMed ID: 23091098
[TBL] [Abstract][Full Text] [Related]
15. Anal squamous cell carcinoma in HIV/AIDS patients in the HAART era: Report of 8 cases and literature review.
Corti M; Villafañe MF; Priarone MM; Vittar N; Lewi D; Marona E; Gilardi L
Acta Gastroenterol Latinoam; 2014; 44(4):305-10. PubMed ID: 26753381
[TBL] [Abstract][Full Text] [Related]
16. Risk factors of high-grade anal intraepithelial neoplasia recurrence in HIV-infected MSM.
Burgos J; Curran A; Landolfi S; Guelar A; Miguel L; Dinares M; Villar J; Navarro J; Hernandez-Losa J; Falcó V
AIDS; 2017 Jun; 31(9):1245-1252. PubMed ID: 28252530
[TBL] [Abstract][Full Text] [Related]
17. HAART and progression to high-grade anal intraepithelial neoplasia in men who have sex with men and are infected with HIV.
de Pokomandy A; Rouleau D; Ghattas G; Trottier H; Vézina S; Coté P; Macleod J; Allaire G; Hadjeres R; Franco EL; Coutlée F
Clin Infect Dis; 2011 May; 52(9):1174-81. PubMed ID: 21364075
[TBL] [Abstract][Full Text] [Related]
18. Use of highly active antiretroviral therapy is associated with lower prevalence of anal intraepithelial neoplastic lesions and lower prevalence of human papillomavirus in HIV-infected men who have sex with men.
van der Snoek EM; van der Ende ME; den Hollander JC; Schutten M; Neumann HA; van Doornum GJ
Sex Transm Dis; 2012 Jul; 39(7):495-500. PubMed ID: 22695316
[TBL] [Abstract][Full Text] [Related]
19. Incident Hepatitis B Virus Infection in HIV-Infected and HIV-Uninfected Men Who Have Sex With Men From Pre-HAART to HAART Periods: A Cohort Study.
Falade-Nwulia O; Seaberg EC; Snider AE; Rinaldo CR; Phair J; Witt MD; Thio CL
Ann Intern Med; 2015 Nov; 163(9):673-80. PubMed ID: 26457744
[TBL] [Abstract][Full Text] [Related]
20. Absolute count and percentage of CD4+ lymphocytes are independent predictors of disease progression in HIV-infected persons initiating highly active antiretroviral therapy.
Hulgan T; Shepherd BE; Raffanti SP; Fusco JS; Beckerman R; Barkanic G; Sterling TR
J Infect Dis; 2007 Feb; 195(3):425-31. PubMed ID: 17205482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
